Trade PALI stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Palisade Bio, Inc. (PALI) is trading at US$1.69, up 6.29% today as of Sep 21, 16:00 EDT. The company has a market capitalisation of US$365.97M. Over the past 52 weeks, PALI has traded between US$0.62 and US$2.86. On Syfe you can trade PALI with $0 commission and add it to your watchlist.
| Previous close | US$1.59 |
|---|---|
| Market cap | US$365.97M |
| 52-week range | US$0.62 – US$2.86 |
| Volume | 3.57M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Palisade Bio, Inc.
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies for inflammatory bowel diseases. Its programs include PALI-2108 and LB1148. The company was founded on September 6, 2011 and is headquartered in Denver, CO.
Year: 2021
--Oppenheimer Initiates Coverage on Palisade Bio With Outperform Rating, $8 Price Target
Jul 23, 11:41 AM · MT Newswires
Palisade Bio Gets FDA IND Clearance for Phase 2 PALI-2108 UC Study
Jun 29, 1:03 PM · MT Newswires
Update: Palisade Bio Shares Fall After Phase 1b Data on PALI-2108 in Fibrostenotic Crohn's Disease
Mar 31, 6:50 PM · MT Newswires
Palisade Bio Says Phase 1b Data Supports PALI-2108's Development as Potential Treatment for Fibrostenotic Crohn's Disease
Mar 30, 8:54 PM · MT Newswires
--HC Wainwright Initiates Coverage on Palisade Bio With Buy Rating, $7 Price Target
Mar 26, 12:43 PM · MT Newswires
Palisade Bio, Inc. (PALI) stock is trading at US$1.69, +6.29% from the previous close of US$1.59.
The market cap for Palisade Bio, Inc. (PALI) stock is approximately US$365.97M.
The 52-week high for Palisade Bio, Inc. (PALI) stock is US$2.86.
The 52-week low for Palisade Bio, Inc. (PALI) stock is US$0.62.
Palisade Bio, Inc. (PALI) does not currently pay a dividend.
Stay on top of PALI
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
